Eyepont Pharmaceuticals (EYPT) Stock Rockets On Expanded License Agreement

Eyepoint Pharmaceuticals EYPT Stock News

Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT) is running for the top in the market this morning, and for good reason. The company announced that it has entered into an expanded license agreement, which included a one-time payment of nearly $10 million. Here’s what’s going on: Stop wasting your time! Start finding winning trades in minutes with … Read more